The OnSite HBV-5 Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection of hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (HBsAb), hepatitis B e-antigen (HBeAg), hepatitis B e-antibody (HBeAb), and hepatitis B core antibody (HBcAb) in human serum or plasma. It is intended to be used by healthcare professionals to aid in the diagnosis of infection with hepatitis B virus (HBV). Any use or interpretation of this preliminary test result must also rely on other clinical findings and the professional judgment of healthcare providers. Alternative test method(s) should be considered to confirm the test results obtained by this device. Panel format cassette to conveniently test for five targets at once Utilize all markers to help distinguish between acute and chronic infections Result in 15 minutes Individually sealed foil pouches containing: One cassette device One desiccant Plastic droppers Package insert (instruction for use) CTK Products at a Glance Inserts Poster U.S. CDC: hepatitis B Virus FAQs for Health Professionals WHO: Health Topic for Hepatitis

HumaScope ClassicLED is Particularly suitable for remote health care settings: Rechargeable battery allows for independence from constant power supply up to 5 days LED illumination: no replacement bulbs required Objective - Semi-Plan achromatic 4x, 10x, 40x, 100x (oil Immersion) Head – Binocular, Compensation Free Eyepiece – Widefield, 10x /18mm, Diopter Adjustment Revolver – Five Positions Reverse These are microscopes for education and routine laboratory applications; they are high-performing, durable imaging systems at affordable prices. They have robust mechanical construction combined with brilliant optics and latest LED technology as well as battery operation mode, making them first choice for health care settings especially in remote areas.

Oscar Chikungunya test is an in vitro diagnostic rapid test based on the principle of immunochromatography on a membrane, for simultaneous and differential detection of Chikungunya specific antibody (IgM/IgG) in human serum/ plasma for diagnosis of Chikungunya infection. For professional use only. Pack Size: 10 Tests Several methods can be used for diagnosis of chikungunya virus infection. Serological tests, such as ELISAs may confirm the presence of IgM and IgG anti-chikungunya antibodies. The virus may also be directly detected in the blood during the first few days of infection by both serological and virological methods (particularly reverse transcriptase–polymerase chain reaction (RT–PCR)). There is no specific antiviral drug treatment for chikungunya. The clinical management targets primarily to relieving the symptoms, including the joint pain using anti-pyretics, optimal analgesics, drinking plenty of fluids and general rest. The joint pain is often very debilitating; it usually lasts for a few days, but may be prolonged for weeks, months or even years--the name “chikungunya” derives from a word in the Kimakonde language, meaning “to become contorted”, and describes the stooped appearance of sufferers with joint pain (arthralgia).

The primer and probe mix adopts the dual-target gene design, which targets the specific conserved sequence encoding the ORF1-ab gene and the Nucleocapsid N gene. With the PCR reaction mix provided, the amplification of template can be monitored by the increasing fluorescence signal detected by a real time PCR instrument. The PCR detection system includes an endogenous internal control primer and probe mix. The result of internal control provides the accuracy of sampling and extraction process, in order to avoid false negative results. Pack Size: 100 Tests